Yahoo Finance - WJSAM Finance Hub

Yahoo Finance

Nebius (NBIS) Loses 7.7% on Dismal Earnings, Share Sale

Nebius (NBIS) Loses 7.7% on Dismal Earnings, Share...

2 weeks ago 17

Lumen (LUMN) Drops 7% on Lack of Leads

Lumen (LUMN) Drops 7% on Lack of Leads

2 weeks ago 8

Exclusive-Nexperia customers in talks over workaround to skirt Europe-China chip feud, sources say

Exclusive-Nexperia customers in talks over workaro...

2 weeks ago 7

BigBear.ai Is Up 17% in a Week. Is It Really the Next Palantir?

BigBear.ai Is Up 17% in a Week. Is It Really the N...

2 weeks ago 8

What Makes an Ethical Dispatch Service

What Makes an Ethical Dispatch Service

2 weeks ago 9

Warner Bros. Discovery just got a boost, and buyers are circling

Warner Bros. Discovery just got a boost, and buyer...

2 weeks ago 9

Dave Ramsey Says To Ask Yourself One Question Before Buying Expensive 'Toys': If You Burned This Money On The Floor, Would Your Life Change?

Dave Ramsey Says To Ask Yourself One Question Befo...

2 weeks ago 9

Earn a best-ever 100,000 miles bonus on the Capital One Venture X

Earn a best-ever 100,000 miles bonus on the Capita...

2 weeks ago 9

Mango Tangos With TextileGenesis for Supply Chain Mapping

Mango Tangos With TextileGenesis for Supply Chain ...

2 weeks ago 19

Pfizer CEO Albert Bourla says aggressive bid for Metsera reflects company's 'right to win' obesity market

Pfizer CEO Albert Bourla says aggressive bid for M...

2 weeks ago 10

Australia eyes Indonesia’s nickel in its play for critical mineral supremacy

Australia eyes Indonesia’s nickel in its play for ...

2 weeks ago 10

Jim Cramer Shows Confidence in Amgen

Jim Cramer Shows Confidence in Amgen

2 weeks ago 11

Jim Cramer Notes Johnson & Johnson is “Really Bearing Down on High-Growth Pharma”

Jim Cramer Notes Johnson & Johnson is “Really Bear...

2 weeks ago 10

Jim Cramer Highlights Clorox’s Performance for the Year

Jim Cramer Highlights Clorox’s Performance for the...

2 weeks ago 11

Jim Cramer on Joby: “They’re Losing Too Much Money”

Jim Cramer on Joby: “They’re Losing Too Much Money...

2 weeks ago 12

Jim Cramer on Aquestive Therapeutics: “I Think It’s a Very Interesting Spec”

Jim Cramer on Aquestive Therapeutics: “I Think It’...

2 weeks ago 11

Jim Cramer on GSI Technology: “I Don’t Think It’s Worth Sticking Your Neck Out”

Jim Cramer on GSI Technology: “I Don’t Think It’s ...

2 weeks ago 13

Jim Cramer on Starbucks: “Maybe the Most Controversial Stock in the 500”

Jim Cramer on Starbucks: “Maybe the Most Controver...

2 weeks ago 11